Postnatal multivitamin and mineral supplement for new mothers
Official title: Effect of a Postpartum Multivitamin-Mineral Supplement on Maternal Nutrient Status and Wellbeing
Run by Perelel Inc. · NCT07303595 · Data updated 2026-11-12
We will test whether a postpartum-specific vitamin and mineral supplement helps improve nutrition and health in women who recently gave birth.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | Perelel Inc. Industry-sponsored |
| Locations | 1 site (Athens, Georgia) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | October 2026 |
| Study ends | October 2026 |
| Registry record updated | December 26, 2025 |
| Trial ID | NCT07303595 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are healthy women about four weeks postpartum (±2 weeks) after a term singleton birth who are not pregnant, can read English or Spanish, and are willing to stop other vitamin/mineral supplements for the 12-week study period.
✕Probably not a fit
Women with cardiometabolic disease, prior pregnancy complications (like gestational diabetes or hypertension), malabsorption disorders, current use of medications that affect nutrient absorption, those prescribed postnatal multivitamins by their physician, or with allergies to product ingredients are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, placebo-controlled study will compare a postpartum-specific multivitamin/mineral supplement to a placebo over 12 weeks in women about four weeks after a term singleton birth. Participants will stop other vitamin/mineral supplements, attend two in-person visits at the University of Georgia Clinical & Translational Unit, and complete two phone calls between visits. Blood samples will be collected to measure vitamin and mineral levels, and urine and breastmilk samples are optional for breastfeeding participants; height, weight, and skinfold measures will also be recorded. The sponsor is Perelel Inc. with collaboration from the University of Georgia and the study is conducted at the UGA site in Athens, Georgia.
Why it matters
Potential benefit: If successful, the supplement could improve postpartum nutrient levels and related outcomes such as energy, recovery, and support for lactation.
How similar studies have gone: Previous research on prenatal and postpartum multivitamins has shown modest improvements in nutrient levels, but postpartum-specific formulations are less well studied and broad clinical benefits remain limited and mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Healthy, postpartum women (\~4 weeks \[± 2 weeks\]) with infants born term and singleton * Not pregnant during the study period * Able to understand (written and spoken) English or Spanish. Exclusion criteria: * Cardiometabolic disease * Past pregnancy complications (gestational diabetes, hypertension) * malabsorption syndromes (IBS, IBD, Crohn's, Colitis, Celiac) * Caily use of medications which may affect nutrient absorption * chronic alcohol use (\> 4 alcoholic drinks/day) * those prescribed postnatal MVM supplements by their physician * unwilling to discontinue dietary supplementation containing any of the active components in the study product over the study period * Women should not have an allergy or intolerance to active or inactive product ingredients.
Where it's running
-
UGA Clinical & Translational Unit
Athens, Georgia, United States Recruiting
Study contacts
- Study coordinator: Sina Gallo, PhD, MSc, RD
- Email: ctru@uga.edu
- Phone: 706-542-4847
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digitally Enabled Districts 2.0: Aimed at Improving Maternal and Neonatal Care in Garut
A stepped-wedge trial tests whether an integrated digital health ecosystem helps 45 local clinics in Garut improve the completeness and timeliness of maternal and neonatal care.
-
Brexanolone therapy for moms with postpartum depression
This trial tests LPCN 1154A against placebo to see if it can help reduce depression symptoms in women with severe postpartum depression.
-
Online biopsychosocial program to improve mental well-being during pregnancy
This trial tests whether a smartphone app with relaxation, stress‑management and mood‑boosting exercises can help pregnant Spanish‑speaking women early in pregnancy feel less anxious and more prepared for motherhood.
-
Online therapy for anxiety and depression in new mothers
This study tests whether an online therapy program can help new mothers with anxiety and depression feel better when combined with their usual treatment.
-
Improving mental health care for pregnant women with mood and anxiety disorders
This study is testing a new way to help pregnant women in Kenya who have mood and anxiety disorders by providing better screening and treatment through their regular health care visits.
-
New treatment for depression after childbirth
This study is testing a new therapy to see if it can help women with depression and anxiety after giving birth feel better and connect more with their babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.